Facebook Twitter LinkedIn Instagram Email Printer Google Plus

COVID-19

Insurance markets showed great resiliency during the past 18 months as employment numbers fluctuated. Looking ahead, multiple legislative, regulatory, and market moves may cause shifts in the payer enrollment mix.

Partner, Health and Life Sciences, Oliver Wyman
Practice Leader, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman
Associate, Oliver Wyman

And How Stakeholders Can, Literally, Save the World

Climate change will be the biggest impact on global health. The healthcare industry may not respond in time.

Director, Marsh & McLennan Advantage Insights
Partner, Health and Life Sciences, Oliver Wyman

How Market Trends and Dynamics are Impacting Insurers' Bottom Lines

An analysis of market profitability and capitalization trends as well as new insights into insurers' recent claims experiences.

Principal, Actuarial, Oliver Wyman
Senior Consultant, Oliver Wyman
Senior Consultant, Oliver Wyman

Part 4: State-by-State Market Impact

Six factors that dictate the kind of health coverage people who've lost their jobs want next.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Oliver Wyman Actuarial Consulting
Senior Consultant, Oliver Wyman

Healthcare Cost and Utilization During COVID-19

An analysis of what claim payments and delays may look like later this year.

Practice Leader, Oliver Wyman Actuarial Consulting
Principal, Actuarial, Oliver Wyman

Insights in your inbox

Subscribe

Rapid Cost Transformation to Establish a Baseline

Sixty-five percent of health plans with total membership in group commercial are at high-risk for negative profitability.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Partner, Financial Services, Oliver Wyman
Senior Consultant, Oliver Wyman

Executives discuss the COVID-19 financial fallout and what future subsequent peaks might look like for health systems.

Market dynamics are ripe for M&A activity. But before being enticed by a mirage, leaders must revisit old lessons.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Social distancing may be necessary for two years or more. Here's where remote care comes into play.

Partner and CMO, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Health plans must maintain a competitive portfolio and double-down on their offerings.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman
Senior Consultant, Oliver Wyman
Principal, FSA, MAAA, Oliver Wyman

Insights in your inbox

Subscribe